NLS PHARMACEUTICS LTD's ticker is NLSPW and the CUSIP is H57830111. A total of 8 filers reported holding NLS PHARMACEUTICS LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,040 | +106.3% | 200,000 | +100.0% | 0.00% | – |
| Q2 2023 | $10,200 | -66.0% | 100,000 | -50.0% | 0.00% | – |
| Q1 2023 | $30,000 | +8.2% | 200,000 | +100.0% | 0.00% | – |
| Q4 2022 | $27,720 | +10.9% | 100,000 | 0.0% | 0.00% | – |
| Q3 2022 | $25,000 | +108.3% | 100,000 | 0.0% | 0.00% | – |
| Q2 2022 | $12,000 | -68.4% | 100,000 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $38,000 | -77.0% | 100,000 | -50.0% | 0.00% | -50.0% |
| Q4 2021 | $165,000 | +7.1% | 200,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $154,000 | -19.8% | 200,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $192,000 | +1.1% | 200,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $190,000 | – | 200,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 827,921 | $2,069,000 | 0.44% |
| Worth Venture Partners, LLC | 194,560 | $161,000 | 0.07% |
| ARMISTICE CAPITAL, LLC | 500,000 | $413,000 | 0.01% |
| Warberg Asset Management LLC | 35,480 | $29,000 | 0.01% |
| Hudson Bay Capital Management LP | 200,000 | $154,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 2,635 | $2,000 | 0.00% |
| Bank Julius Baer & Co. Ltd, Zurich | 7,370 | $6,000 | 0.00% |